AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
AEON Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.23−0.00 (-0.43%)
Close on Oct 19, 2026
- Market cap
- $11.67M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
AEON Biopharma has not reported a dividend
No dividend per share appears in AEON Biopharma's annual filings since fiscal 2020.